OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.400
0.00 (0.00%)
At close: Sep 14, 2026, 4:00 PM EDT
1.400
0.00 (0.00%)
After-hours: Sep 14, 2026, 4:10 PM EDT

OKYO Pharma Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Quarter
H2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Net Income
-6.36-2.59-2.03-2.68-8.01-8.82-7.64-5.08-3.02-2.48
Depreciation & Amortization
00000000-0.010.02
Loss (Gain) From Sale of Assets
---------0-
Stock-Based Compensation
1.060.550.810.60.540.590.610.630.950.87
Other Operating Activities
0.081.950.45-0.593.55-0.020.190.11-0.6-0.22
Change in Accounts Receivable
0.18-0.180.2-0.2-0.40.4-0.140.120.03-0.01
Change in Accounts Payable
-0-0.64-0.832.541.071.162.80.880.8-1.08
Change in Other Net Operating Assets
0.64-0.63-0.180.090.54-0.10.070.09-0.76-0.04
Operating Cash Flow
-4.41-1.53-1.57-0.24-2.7-6.79-4.1-3.24-2.61-2.94
Operating Cash Flow Growth (YoY)
----------

Investing Activities

Fiscal Quarter
H2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Capital Expenditures
-0.01--0----0-0-0-
Investment in Securities
-6---------
Investing Cash Flow
-6.01--0----0-0-0-

Financing Activities

Fiscal Quarter
H2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Short-Term Debt Issued
---0------
Total Debt Issued
--0.950--2---
Long-Term Debt Repaid
----------0.01
Lease Payments
--------0.01-0.01
Total Debt Repaid
--------0.01-0.01
Net Debt Issued (Repaid)
--0.950--2-0.01-0.01
Issuance of Common Stock
20.714.321.160.552.2144.852.230.781.41
Other Financing Activities
------0.64-0.58--
Financing Cash Flow
20.714.322.10.552.2147.491.650.791.4

Net Cash Flow

Fiscal Quarter
H2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Foreign Exchange Rate Adjustments
0.08-0.130.04-0.15-0.30.36-0.28--0.87-
Net Cash Flow
10.372.660.570.16-0.79-2.433.1-1.58-2.69-1.54

Free Cash Flow

Fiscal Quarter
H2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Free Cash Flow
-4.41-1.53-1.57-0.24-2.7-6.79-4.11-3.24-2.61-2.94
Free Cash Flow Growth (YoY)
----------
Free Cash Flow Per Share
-0.12-0.04-0.04-0.01-0.08-0.26-0.18-0.15-0.16-0.21
Levered Free Cash Flow
-1.37-0.73-2.27-0.45-3.09--1.35-1.28-1.87-2.09
Unlevered Free Cash Flow
-1.13-0.68-2.20.02-2.44--1.29-1.28-1.87-2.09
Free Cash Flow After Leases
-4.41-1.53-1.57-0.24-2.7-6.79-4.11-3.24-2.59-2.95

Additional Metrics

Fiscal Quarter
H2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Cash Income Tax Paid
0.01-1.96--0.56----0.17--
Change in Working Capital
0.81-1.44-0.82.431.211.462.731.090.07-1.13
SEC Filings: 10-K · 10-Q